Unlocking the secret drivers of deadly pancreatic cancer: New target offers hope for treatment

Researchers identify a super-enhancer-regulated RNA-binding protein cascade that drives the growth of pancreatic ductal adenocarcinoma, a deadly form of pancreatic cancer. The discovery offers a promising new avenue for targeted therapy, potentially sidestepping severe side effects associated with other treatments.

Endpoints 11 winner Xaira Therapeutics: Biotech’s largest AI bet with A-list backers

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 27, 2024

Maintaining optimal heart health after pregnancy can mitigate cardiovascular disease risk

Women with a history of adverse pregnancy complications are at significantly higher risk of developing heart disease but can reduce their risk by maintaining optimal

March 22, 2024

Gilead’s short-term win threatens the future of pharmaceutical public-private partnerships

On Dec. 19, 2024, we joined other professors of law, medicine, and public health to file an amicus brief in support of the U.S. government

February 12, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.